Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Cantor Fitzgerald
Queensland Health
Argus Health
US Department of Justice

Generated: August 17, 2017

DrugPatentWatch Database Preview

MIXTARD HUMAN 70/30 Drug Profile

« Back to Dashboard

Which patents cover Mixtard Human 70/30, and when can generic versions of Mixtard Human 70/30 launch?

Mixtard Human 70/30 is a drug marketed by Bayer Pharms and is included in one NDA.

The generic ingredient in MIXTARD HUMAN 70/30 is insulin recombinant purified human; insulin susp isophane semisynthetic purified human. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin recombinant purified human; insulin susp isophane semisynthetic purified human profile page.

Summary for Tradename: MIXTARD HUMAN 70/30

Clinical Trials: see list7,620
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MIXTARD HUMAN 70/30 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms
insulin recombinant purified human; insulin susp isophane semisynthetic purified human
INJECTABLE;INJECTION019585-001Mar 11, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Johnson and Johnson
Boehringer Ingelheim
Chinese Patent Office
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus